Loading briefing details...
Loading briefing details...
News Abstract
By: NewsAbstract Editorial Team
Topic: Health
April 2, 2026
Chris Bauer's appointment as SVP of Strategy & Market Commercialization is crucial for New Horizon Medical Solutions. His vast experience will accelerate NHMS's growth, optimize commercial strategies, and enhance market penetration in advanced wound care. This move signifies a stronger focus on innovation and expanding access to critical patient solutions, elevating industry standards.
LAS VEGAS, NV – April 2, 2026 – New Horizon Medical Solutions (NHMS), a rapidly expanding innovator in advanced wound care technologies, today announced the appointment of Chris Bauer as Senior Vice President of Strategy & Market Commercialization. In this pivotal role, Bauer will spearhead NHMS's strategic growth initiatives, focusing on optimizing commercial operations, expanding market reach, and enhancing provider engagement. This appointment reinforces NHMS's commitment to advancing wound management.
Bauer brings over 26 years of extensive experience spanning marketing, sales, business development, and finance across the medical device and advanced wound care sectors. His distinguished career includes senior commercial leadership at global healthcare organizations like 3M, KCI, ConvaTec, and Johnson & Johnson, alongside high-growth startups. NHMS CEO, Will Hall, noted, "Chris brings a powerful combination of strategic insight and commercial execution... instrumental as we accelerate our growth."
At NHMS, Bauer will refine the company's go-to-market strategy, streamline commercialization pathways, and strengthen partnerships. His proven ability to scale national sales organizations is expected to significantly accelerate the adoption of NHMS’s innovative biologics portfolio and integrated practice solutions. Bauer expressed enthusiasm, stating, "I look forward to expanding our reach and delivering meaningful outcomes for patients and providers."